Home > > > Veterinary mRNA Vaccines Market to Reach USD 52.18 Million by 2034 | CAGR 11.0%

Veterinary mRNA Vaccines Market to Reach USD 52.18 Million by 2034 | CAGR 11.0%

Author : shivani ghodake | Published On : 09 Oct 2026

According to a report by IntelMarketResearch, global Veterinary mRNA Vaccines Market was valued at USD 20.4 million in 2025 and is estimated to reach USD 22.64 million in 2026, before growing to USD 52.18 million by 2034 at a CAGR of 11.0% during 2026–2034. Growing animal disease threats, demand for rapidly adaptable vaccine platforms, expanding poultry vaccination programs, and increasing investment in self-amplifying RNA and RNA-particle technologies are driving market development.

Explore the full report: https://www.intelmarketresearch.com/global-veterinary-mrna-vaccines-forecast-2025-2032-126-2681

Why Is Demand Increasing

 

  • Rapid Disease Response: RNA platforms can be redesigned by changing antigen sequences, supporting faster responses to rapidly evolving animal pathogens.
  • Poultry Disease Control: Recurring avian influenza outbreaks and large-scale poultry vaccination requirements are creating significant opportunities for rapidly adaptable vaccine technologies.
  • RNA Platform Commercialization: Existing RNA-particle veterinary products and growing self-amplifying RNA programs are strengthening commercial validation of RNA-based animal vaccines.

 

Veterinary mRNA Vaccines Watch: Self-Amplifying RNA and Rapid-Response Platforms

Veterinary RNA vaccine development is expanding beyond conventional mRNA-LNP approaches to include self-amplifying RNA and RNA-particle technologies. These platforms can offer programmable antigen expression and potential manufacturing advantages, while non-invasive delivery methods are being explored to reduce labor and simplify mass vaccination in poultry and livestock.

Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/2681/global-veterinary-mrna-vaccines-forecast-2025-2032-126

Segmentation Highlights

 

  • By Type: Injectable Drug Administration and Non-invasive Drug Administration, with injectable administration currently leading due to established individual-dose workflows.
  • By Application: Poultry, Livestock, and Others, with poultry representing the leading application because of large-scale vaccination requirements.
  • By Region: North America, Europe, Asia-Pacific, South America, and Middle East & Africa, with North America leading current market development.

 

Regional Outlook

 

  • North America: Leads the market due to established veterinary RNA-product pathways, active animal-health biotechnology development, and strong investment in livestock vaccine technologies.
  • Europe: Remains strategically important, supported by large-scale poultry vaccination programs and development of self-amplifying RNA vaccine platforms.

 

Download the free sample report: https://www.intelmarketresearch.com/download-free-sample/2681/global-veterinary-mrna-vaccines-forecast-2025-2032-126

Why This Market Matters

Veterinary mRNA vaccines offer a programmable approach to animal immunization that can be particularly valuable for rapidly evolving pathogens. The technology is gaining attention across poultry, livestock, and companion-animal applications as manufacturers seek faster vaccine redesign, scalable production, and improved responses to emerging disease threats. Field deployment of self-amplifying RNA and licensed RNA-particle products is also helping reduce commercialization uncertainty.

Competitive Landscape

 

  • Ceva Animal Health: Advances self-amplifying RNA vaccine development and has established a major position in poultry vaccination programs.
  • Merck Animal Health: Maintains a strong veterinary vaccine portfolio and has licensed RNA-particle products across multiple animal-health applications.
  • Genvax Technologies: Focuses on RNA plus nanoparticle vaccine platforms for rapid-response livestock and poultry applications.
  • Areterna LLC: Participates in the emerging veterinary RNA vaccine development ecosystem and platform technologies.
  • BioNTech SE: Brings extensive mRNA technology expertise that can support future animal-health applications and platform development.

 

View the full report: https://www.intelmarketresearch.com/global-veterinary-mrna-vaccines-forecast-2025-2032-126-2681

FAQ

What is the current size of the Veterinary mRNA Vaccines Market? The global market was valued at USD 20.4 million in 2025 and is estimated to reach USD 22.64 million in 2026.

What will the Veterinary mRNA Vaccines Market be worth by 2034? The market is projected to reach USD 52.18 million by 2034 at a CAGR of 11.0%.

Which application leads the market? Poultry is the leading application, driven by large-scale vaccination requirements and the need for rapidly adaptable responses to avian diseases.

What Does the Full Report Cover?

The full report provides detailed analysis of the global Veterinary mRNA Vaccines Market by administration type, animal application, technology platform, and region. It examines market sizing and forecasts, competitive positioning, vaccine development, RNA-particle technologies, self-amplifying RNA, rapid strain updating, poultry and livestock disease control, non-invasive delivery, manufacturing economics, cold-chain requirements, regulatory pathways, market drivers, challenges, opportunities, and regional growth prospects through 2034.

View the complete report: https://www.intelmarketresearch.com/global-veterinary-mrna-vaccines-forecast-2025-2032-126-2681 Download the free sample: https://www.intelmarketresearch.com/download-free-sample/2681/global-veterinary-mrna-vaccines-forecast-2025-2032-126

Related Reports

 

 

About IntelMarketResearch

IntelMarketResearch provides market intelligence, industry analysis, competitive assessments, and strategic research across global industries. Its reports deliver market sizing, forecasts, segmentation, regional analysis, company profiles, and insights into emerging technologies and business trends.

Contact Details

IntelMarketResearch Website: https://www.intelmarketresearch.com Email: [email protected] Phone: +91 916 916 4321 Linkedin: Follow us